SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kilitch Drugs (India) informs about loss of share certificate

22 Oct 2024 Evaluate
Kilitch Drugs (India has informed that the Company has received intimation in relation with stop transfer due to loss of share certificate by shareholder from the Registrar and Share Transfer Agents of the Company, Link Intime India.

The above information is a part of company’s filings submitted to BSE.

Kilitch Drugs(India) Share Price

129.50 -0.40 (-0.31%)
16-Apr-2026 13:06 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1679.40
Dr. Reddys Lab 1223.00
Cipla 1230.60
Zydus Lifesciences 936.35
Lupin 2300.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×